Schedule 13D ownership disclosure

HEPION PHARMACEUTICALS INC

Common Stock, par value $0.0001 per share · CUSIP: 426897401

Event date: 2026-10-06

Filing-level shares
25,000,000.00
Percent of class
19.9%
  • Gravitas Collective Corp.Reported CIK 0002161196

    Shares: 25,000,000.00 · Class: 19.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-048601
Form type
SCHEDULE 13D
Filer
Gravitas Collective Corp.
CIK
CIK 2161196
Filed
Oct 26, 2026
Reporting period
Oct 06, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub